Tag Archives: NASDAQ:SESN

Canaccord Genuity Reaffirms Their Buy Rating on Sesen Bio (SESN)

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Monday at $1.12. According to TipRanks.com, Newman is a 5-star analyst

Canaccord Genuity Keeps a Buy Rating on Sesen Bio (SESN)

In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $1.29. According to TipRanks.com, Newman is

Sesen Bio (SESN) Gets a Buy Rating from Canaccord Genuity

In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Sesen Bio (SESN – Research Report), with a price target of $5.00. The company’s shares closed last Monday at $1.06. According to TipRanks.com, Newman is

Canaccord Genuity Thinks Sesen Bio’s Stock is Going to Recover

Canaccord Genuity analyst John Newman maintained a Buy rating on Sesen Bio (SESN – Research Report) yesterday and set a price target of $5.00. The company’s shares closed last Tuesday at $0.69, close to its 52-week low of $0.37. According

Sesen Bio Inc (SESN) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Hold rating on Sesen Bio Inc (SESN – Research Report) today and set a price target of $1. The company’s shares closed yesterday at $1.13. Ramakanth said: “We maintain our Neutral rating of